Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-04-17 | New | $158,300,000 | $158,300,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Mark Alles | Director, Executive |
| Mark Attanasio | Director |
| David Licata | Director, Executive |
| Neil O'brien | Director |
| Lynn Seely | Director |
| Amit Sinha | Director |
| Dennis Slamon | Director |